Skip to main content
Caplight Logo









Corion Biotech

Corion Biotech

Private
TurinHealthcare & Life Scienceshttps://www.corionbiotech.com/

Last Round

Seed

Sep 11, 2020

Total Funding Raised

$1.18M

Company Overview

Corion Biotech is a biotechnology company that develops innovative therapeutic solutions for women's health, specifically focusing on treatments for preeclampsia and epithelial cancers using placental-derived cell technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

cell therapyregenerative medicineplacental mesenchymal stromal cellshPDMSCscell-free therapybiologicsdrug discoverywomen's healthpreeclampsia treatmentgynecological cancerexosome therapybiotech startuptranslational research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Corion Biotech Comparables

Compare Corion Biotech with similar companies based on industry and business-model similarity.

Corion Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EXO Biologics
76%
Secretome Therapeutics
73%
Beech Biotech SA
70%

Corion Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 11, 2020

Key People

Founding team and executive leadership

Tullia Todros

Founder and CEO Corion Biotech

Founding Team

Corion Biotech Investors

Notable investors and investment history

Corion Biotech investors
InvestorRounds
LIFTT EuroInvestSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 138% MoM.

  • Jul 8, 2025

    Monthly visitors increased 45% to 1.6K.

Corion Biotech Filings

Explore SEC and related filing metadata, where available.

Corion Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Corion Biotech's valuation, stock price, and market status.

Is Corion Biotech a public or private company?

Corion Biotech is a private company.

What is the current stock price of Corion Biotech?

Corion Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Corion Biotech worth (valuation)?

Valuation information for Corion Biotech is not publicly available.

Can I buy Corion Biotech stock?

Corion Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Corion Biotech's last funding round?

Corion Biotech's most recent funding round was Seed on September 11, 2020.

Who are the main investors in Corion Biotech?

Key investors in Corion Biotech include LIFTT EuroInvest.

Will Corion Biotech IPO soon?

No public IPO plans have been announced for Corion Biotech.

How can I track Corion Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Corion Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTurin
Employee Range4
Year Founded2012
Last FundingSep 11, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?